Protara Therapeutics (TARA) Stock Price, Quote, News & History | Benzinga

Protara Therapeutics Inc (TARA) Stock Price, Quote, News & History

TARANASDAQ

Trade with Public

Trade with Public

$4.41

0.194.50%

At close: Jun 4, 5:00 PM EST

$4.41

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$4.26

Close

$4.41

Volume / Avg.

377.63K / 771.64K

Day Range

$4.25 - $4.47

52 Wk Range

2.77 - 7.82

Market Cap

$247.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

6.77%

Days to Cover

5.61

Recent Protara Therapeutics Inc News

Protara Therapeutics Reports 55% Complete Response Rate In Bladder Cancer Study

Protara reports updated Phase 2 data showing durable responses and favorable safety for TARA-002 in bladder cancer patients.

Vandana Singh

Protara's Experimental Bladder Cancer Drug Shows Encouraging Results

Protara Therapeutics (TARA) shares down after release of interim results for TARA-002 treatment of Non-Muscle Invasive Bladder Cancer.

Vandana Singh

What's Going On With Protara Therapeutics Stock Wednesday?

TARA-002, a cell-based therapy by Protara Therapeutics, shows promising results in treating lymphatic malformations in pediatric patients.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-63.00M

Investing Cash Flow (TTM)

-95.86M

Financing Cash Flow (TTM)

82.13M

Free Cash Flow (TTM)

-63.05M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-76.72M

Analyst Trends and Forecast

1

Jan

1

Feb

1

Mar

1

Apr

2

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$121.31M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.31

Earnings Yield % (TTM)

-32.19%

Earnings Yield % (FWD)

-31.12%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.22

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$14.74M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.26

Close

$4.41

Volume / Avg.

377.63K / 771.64K

Day Range

$4.25 - $4.47

52 Wk Range

2.77 - 7.82

Market Cap

$247.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

6.77%

Days to Cover

5.61

About

Sector

Health Care

Industry

Biotechnology

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Protara Therapeutics (TARA) stock?

A

You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Protara Therapeutics (TARA) competitors?

A

There are no as such competitors for Protara Therapeutics.

Q

What is the forecast, or price target, for Protara Therapeutics (TARA) stock?

A

Protara Therapeutics has a consensus price target of $22.58.

Q

What is the current price for Protara Therapeutics (TARA)?

A

The stock price for Protara Therapeutics (NASDAQ: TARA) is $4.41 last updated June 4, 2026 at 4:00 PM EDT.

Q

Does Protara Therapeutics (TARA) pay a dividend?

A

There are no upcoming dividends for Protara Therapeutics.

Q

When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?

A

Protara Therapeutics does not have any upcoming earnings scheduled.

Q

Is Protara Therapeutics (TARA) going to split?

A

There is no upcoming split for Protara Therapeutics.

Q

What sector and industry does Protara Therapeutics (TARA) operate in?

A

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.